Parkinsonian Disorders  >>  levodopa/benserazide  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
levodopa/benserazide / Generic mfg.
NCT01568034 / 2008-003869-72: A Study to Investigate the Tolerability and Effect of Three Single-dose Regimens of BIA 9-1067

Completed
2
10
Europe, RoW
BIA 9-1067, OPC, Opicapone, Placebo, PLC, Levodopa/Carbidopa, Sinemet, Levodopa/Benzerazide, Madopar®/Restex®
Bial - Portela C S.A.
Parkinson's Disease
02/10
02/10
NCT01568047 / 2009-012897-12: Multicentre Study in Four Parallel Groups of Parkinson's Disease (PD) Patients

Completed
2
40
Europe, RoW
Placebo, PLC, BIA 9-1067, OPC, Opicapone, Levodopa/Carbidopa, Sinemet, Levodopa/Benzerazide, Madopar®/Restex®
Bial - Portela C S.A.
Parkinson's Disease
06/10
06/10

Download Options